Gemfibrozil and Rosuvastatin interaction

Gemfibrozil and Rosuvastatin: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Gemfibrozil (Lopid) label · effective 2026-05-21

Major

Avoid concomitant use of LOPID with rosuvastatin.

Drug interactionsnames RosuvastatinView label on DailyMed
Major

If concomitant use cannot be avoided, initiate rosuvastatin at 5 mg once daily.

Drug interactionsnames RosuvastatinView label on DailyMed
Major

Drug Interactions (A) HMG-CoA Reductase Inhibitors The concomitant administration of LOPID with simvastatin is contraindicated (see CONTRAINDICATIONS and WARNINGS ).

Drug interactionsby drug classView label on DailyMed
Moderate

OATP1B1 substrates – Gemfibrozil is an inhibitor of organic anion-transporter polyprotein (OATP) 1B1 and may increase exposure of drugs that are substrates of OATP1B1 (e.g., atrasentan, atorvastatin, bosentan, ezetimibe, fluvastatin, glyburide, SN-38 [active metabolite of irinotecan], rosuvastatin, pitavastatin, pravastatin, rifampin, valsartan, olmesartan).

Warningsnames RosuvastatinView label on DailyMed
Moderate

The dose of rosuvastatin should not exceed 10 mg once daily.

Drug interactionsnames RosuvastatinView label on DailyMed

From the Rosuvastatin (Crestor) label · effective 2026-04-29

Major

Steps to Prevent or Reduce the Risk of Myopathy and Rhabdomyolysis The concomitant use of CRESTOR with cyclosporine or gemfibrozil is not recommended.

Warnings and precautionsnames GemfibrozilView label on DailyMed
Major

Gemfibrozil Prevention or Management: Avoid concomitant use of gemfibrozil with CRESTOR.

Drug interactionsnames GemfibrozilView label on DailyMed
Moderate

Mechanism and Clinical Effect(s): Gemfibrozil significantly increased rosuvastatin exposure and gemfibrozil may cause myopathy when given alone.

Drug interactionsnames GemfibrozilView label on DailyMed
Moderate

Niacin, fibrates, and colchicine may also increase the risk of myopathy and rhabdomyolysis [see Drug Interactions (7.1) ] .

Warnings and precautionsby drug classView label on DailyMed
Moderate

Fenofibrates (e.g., fenofibrate and fenofibric acid) Prevention or Management: Consider if the benefit of using fibrates concomitantly with CRESTOR outweighs the increased risk of myopathy and rhabdomyolysis.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.